dorsaVi Stock

dorsaVi EV/EBIT

The EV/EBIT (Enterprise Value to EBIT) of dorsaVi (DVL.AX) as of Aug 5, 2026 is -19.83. In the previous year, EV/EBIT (Enterprise Value to EBIT) was -21.77 — a change of -8.93% (higher).

EV/EBIT

-19.83

YoY

-8.93%

Last updated:

EV/EBIT (Enterprise Value to EBIT) of dorsaVi is 2026 -19.83 . EV/EBIT (Enterprise Value to EBIT) of dorsaVi was 2025 -21.77 . It decreases by -8.93% higher compared to the previous year.

The dorsaVi EV/EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

PRICE-TO-EBIT
Date
PRICE-TO-EBIT
Jan 1, 2018
-1.07 base
Jan 1, 2019
-0.46 base
Jan 1, 2020
-2.35 base
Jan 1, 2021
-1.92 base
Jan 1, 2022
-1.70 base
Jan 1, 2023
-2.40 base
Jan 1, 2024
-3.84 base
Jan 1, 2025
-11.95 base
YEARPRICE-TO-EBIT
2025 -11.95
2024 -3.84
2023 -2.40
2022 -1.70
2021 -1.92
2020 -2.35
2019 -0.46
2018 -1.07
2017 -5.01
2016 -6.59
2015 -2.64
2014 -2.79
2013 -5.63
2012 -
2011 -
2010 -
Access this data via the Eulerpool API

dorsaVi Valuation

Details

Historical Valuation Multiples

Price-to-Earnings Ratio (P/E)

The P/E ratio divides dorsaVi's share price by its earnings per share. It tells you how many years of current earnings you are "paying for" when you buy the stock. A P/E of 20 means you pay $20 for every $1 of annual earnings. The S&P 500 historically trades at an average P/E of roughly 15–17. A P/E significantly above that may signal high growth expectations; one below may indicate undervaluation — or declining business quality.

Price-to-Sales Ratio (P/S)

The P/S ratio divides market capitalization by total revenue. Unlike the P/E ratio, it works even for companies that are not yet profitable, making it essential for evaluating high-growth firms. A P/S below 1.0 may indicate undervaluation, while ratios above 10 are typically reserved for fast-growing tech or SaaS companies with high expected future margins.

Price-to-EBIT Ratio

This ratio relates dorsaVi's market price to its operating earnings, excluding the effects of debt structure and tax jurisdiction. It is particularly useful for comparing companies across different countries or with different levels of leverage, because it focuses purely on operational profitability. Lower values suggest cheaper operational earnings.

How to Use This Chart

This chart plots dorsaVi's valuation multiples over time. Compare the current P/E, P/S, and P/EBIT to their own historical averages — if the current ratio is well below the multi-year average, the stock may be relatively cheap compared to its own track record. Combine this with industry comparisons: a P/E that looks high in absolute terms may be justified if dorsaVi grows earnings faster than its peers.

dorsaVi Stock analysis

What does dorsaVi do? The company dorsaVi Ltd is a leading company in the field of wearable technology based in Australia. The company was founded in 2000 by Andrew Ronchi, Andrew Dalziel, and Daniel Dorsch with the vision to improve people's health through the development of technologies that can measure human movement and performance. dorsaVi's business model is based on the development and marketing of wearable technology for use in medicine, rehabilitation, and sports. The company aims to develop innovative, user-friendly, and reliable devices that help users optimize their movement and performance. The products are used by professional athletes, physiotherapists, trainers, and doctors worldwide. dorsaVi's mission is to improve the health and well-being of people and prevent injuries by providing accurate and easy-to-use solutions. The company is built on three main pillars: Sports, Clinical, and Occupational. Each of these pillars has specific products and solutions to help users in different industries and application areas. In the Sports field, dorsaVi offers a wide range of products and solutions for professional athletes and trainers to optimize their performance and prevent injuries. The company's flagship product is the ViPerform system. This system allows athletes to accurately analyze and improve their movements during training or competition. It consists of wireless sensors attached to various parts of the body to capture data on movements, speed, acceleration, and force. The data is then sent to the dorsaVi app in real-time, where it can be analyzed, visualized, and interpreted. In the Clinical field, dorsaVi provides solutions for therapists and doctors to support patients in their recovery after an injury or surgery. The Sentral Clinical Movement Analysis System offered in this field is an advanced system for analyzing human movement. It allows therapists to observe and analyze movement patterns accurately to identify disruptions and weaknesses that may lead to pain or injuries. The collected data can help create individual therapy plans and accelerate recovery. In the Occupational field, dorsaVi develops solutions for companies and employees to improve their health and safety in the workplace. This includes the Sentral Wearable Movement Monitoring System. The system is a wireless and non-invasive solution that allows employers and employees to record and analyze their movement and load profiles in real-time. The collected data can help make ergonomic adjustments in the workplace to prevent injuries and illnesses. Over the years, dorsaVi has received numerous awards for its products and solutions. However, the company continues to strive to develop innovative technologies and products to help people optimize their movement and performance, increase their well-being, and maintain their long-term health. dorsaVi is one of the most popular companies on Eulerpool.

Frequently Asked Questions about dorsaVi stock

EV/EBIT (Enterprise Value to EBIT) of dorsaVi is -19.83 in 2026.

EV/EBIT (Enterprise Value to EBIT) of dorsaVi changed from -21.77 to -19.83, representing a -8.93% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/EBIT (Enterprise Value to EBIT) dorsaVi since 2006 – with annual values, charts, and detailed analysis.

The EV/EBIT ratio measures a company's enterprise value relative to its operating earnings. It accounts for debt, making it useful for comparing companies with different capital structures.

EV/EBIT = Enterprise Value / Earnings Before Interest and Taxes

To evaluate EV/EBIT (Enterprise Value to EBIT)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/EBIT (Enterprise Value to EBIT).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/EBIT (Enterprise Value to EBIT)'s dorsaVi with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — dorsaVi

All Key Metrics — dorsaVi